China’s prenatal and neonatal devices market accounted for USD XX billion in 2016 and is expected to reach USD XX billion by 2021, growing at a CAGR of XX% during the forecast period from 2016 to 2021. Fetal and neonatal equipment are mostly used to monitor, evaluate and treat diseases in the prenatal and postnatal stages of infants.
Premature and congenitally ill infants are born as a result of advanced maternal age, induced fertility, labor treatments, poor prenatal care, and changes in lifestyle preferences. Prevalence of various disorders like anemia, bronchopulmonary dysplasia, and intra- ventricular hemorrhage are diagnosed at the time of birth and this helps in the growth of the fetal and neonatal care market.
China Neonatal and Prenatal Devices Market-Market Dynamics
The report details several factors driving and restraining the market. In addition, the report also discusses the opportunities and challenges that market players face. Some of these are listed below.
The China fetal and neonatal care market is driven by various factors like
The presence of a highly competitive market is turning out to be a restraint to this market.
The growing popularity of fetal MRI, technological innovations and the high demand for portable and versatile systems are some of the opportunities for the market players.
Market players face the challenges of the increasing product recalls, lack of awareness and economic constraints in developing countries.
China’s prenatal and neonatal market can be segmented into prenatal and fetal equipment, neonatal equipment and others. The prenatal and fetal equipment market is further segmented into ultrasound and ultrasonography devices, fetal Dopplers, fetal magnetic resonance imaging (MRI), and fetal monitors. Based on neonatal equipment, the market is further segmented into infant warmers and incubators, phototherapy equipment, neonatal monitoring devices and respiratory assistance and monitoring devices.
Some of the key players in the market are:
What the Report Offers
1.1 Study deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and forecast period years
1.6 General Study Assumptions
2. RESEARCH METHODOLOGY
2.2 Analysis Methodology
2.3 Econometric forecast models
2.4 Research Assumptions
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW AND INDUSTRY TRENDS
5.1 Current market scenario
5.2 Technology Overview
5.3 New developments in therapeutics
5.4 Investment analysis
5.5 Porter’s Five Force Analysis
5.5.1 Bargaining Power of suppliers
5.5.2 Bargaining power of buyers
5.5.3 Degree of competition
5.5.4 Threat of substitution
5.5.5 Threat of new entrants
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 Market Drivers
6.1.1 Rising Incidence of Preterm Births
6.1.2 Increasing Awareness for Prenatal and Neonatal Care
6.1.3 Increased demand of Prenatal Therapeutics, Diagnostics and Monitoring Devices
6.1.4 Government initiatives to provide better care for prenatal and neonatal infants
6.1.5 Growing Birth rate in China
6.2 Market Restraints
6.2.1 Competitive market
6.3 Market Opportunities
6.3.1 Growing Popularity of Fetal MRI
6.3.2 Technological innovations
6.3.3 High demand for portable & versatile systems
6.4 Key Challenges
6.4.1 Increase in Product Recalls
6.4.2 Lack of awareness and economic constraints in developing countries
7. China Prenatal and neonatal Market Segmentation
7.1 By Product Type
7.1.1 Prenatal and Fetal Equipment
22.214.171.124 Ultrasound and Ultrasonography Devices
126.96.36.199 Fetal Dopplers
188.8.131.52 Fetal Magnetic Resonance Imaging (MRI)
184.108.40.206 Fetal Monitors
7.1.2 Neonatal Equipment
220.127.116.11 Infant Warmers and Incubators
18.104.22.168 Phototherapy Equipment
22.214.171.124 Neonatal Monitoring Devices
126.96.36.199 Respiratory Assistance and Monitoring Devices
7.1.3 Other Prenatal and neonatal equipment
8. China prenatal and neonatal market by Geography
8.2 China Market
9. COMPETITIVE LANDSCAPE
9.1 Mergers & Acquisitions
9.2 New Product Launches
9.3 Agreements, Collaborations & Partnerships
10. KEY VENDORS
10.1 CareFusion Corporation
10.2 Cooper Surgical, Inc.
10.3 Covidien PLC
10.4 Fisher & Paykel Healthcare Limited
10.5 Fujifilm SonoSite, Inc.
10.6 Getinge AB
10.7 Nonin Medical, Inc.
10.8 Philips Healthcare
10.9 GE Healthcare
10.10 Roche Holding
11. Analyst outlook for Investment Opportunities
12. Future outlook of the market